Background: Intrahepatic cholangiocarcinoma (IHCC) is the second most prevalent type of primary liver malignancy and has less than a 25% 5-year survival rate. Over the last two decades, the incidence of IHCC has been on the rise, however, the trends in mortality related to this form of malignancy are yet to be explored. Therefore, our [...]